首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

市場調查報告書

商品編碼

1801926

醫學影像市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Medical Imaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年08月05日 | 出版商:

Global Market Insights Inc. | 英文 133 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024年，全球醫學影像市場規模達439億美元，預計到2034年將以5.7%的複合年成長率成長，達到758億美元。這一成長主要得益於慢性病負擔的加重、人口老化加劇、影像技術的持續進步以及新興國家和已開發國家醫療支出的增加。醫學影像仍然是臨床診斷和治療計劃的基石，因為它使醫護人員能夠清楚地觀察內臟器官、組織和骨骼。這些技術有助於早期疾病發現、指導微創手術，並有助於患者的長期管理。硬體和軟體的創新、影像清晰度的提升以及影像處理速度的加快，正在進一步提升臨床決策水平，改善患者預後，並刺激全球醫學影像市場的需求。

醫學影像依賴產生高清視覺資料的技術，以協助臨床評估和外科手術干預。這些工具已發展成為診斷的重要組成部分，為各個醫學學科提供精準度和速度。 MRI 系統、X 光、CT 掃描儀和超音波等設備已廣泛應用於臨床，用於評估內傷、慢性病和異常情況。它們的即時成像功能支援診斷並提高工作流程效率。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	439億美元
預測值	758億美元
複合年成長率	5.7%

2024年，X光設備細分市場引領市場，主要得益於其在慢性病早期診斷的應用日益廣泛。該細分市場的成長得益於X光技術的不斷升級，如今包括人工智慧成像解決方案在內的先進技術旨在確保準確性、簡化工作流程並減輕放射科醫生的負擔。這些先進的系統已在多中心評估中證明了其有效性，並在臨床機構中廣泛使用。智慧診斷功能的融入顯著增強了醫療機構的信心，並促進了X光系統在現代醫學影像實踐中的應用不斷提升。

2024年，醫院市場佔據52.6%的市場。快速城鎮化、人口成長以及醫療基礎設施投資的增加推動了醫院市場佔有率的成長。先進診斷設備的廣泛應用，加上熟練操作這些設備的專業人員，使得醫院成為該市場的主要終端使用者。此外，醫院升級和新建專案的資金投入增加，尤其是在發展中地區，也推動了影像設備的普及。政府和私人部門對醫院基礎設施改善的投資，正在推動對高性能影像技術的巨大需求。

2024年，美國醫學影像市場規模達151億美元。受環境和生活方式因素影響，美國癌症發病率不斷上升，這加劇了對用於早期癌症檢測和監測的有效先進影像工具的需求。此類疾病的發生率不斷上升，促使醫院和診所投資於具有高診斷價值和患者特異性精準度的影像系統，加速美國整體市場的成長。

在全球醫學影像市場營運的知名公司包括 GE HealthCare Technologies、Shimadzu、Samsung Medison、Carestream Health、佳能醫療系統、富士膠片控股、Hologic、柯尼卡美能達、Esaote、西門子醫療和荷蘭皇家飛利浦。領先的醫學成像公司正在優先考慮創新，透過投資人工智慧整合、機器學習演算法和自動化來提高影像準確性和診斷速度。他們正在擴展其數位健康平台，以支援遠端診斷、基於雲端的影像儲存和資料互通性。全球市場參與者正在積極尋求與醫院和科技公司的合併、收購和合作，以拓寬其解決方案組合。在本地化製造和服務中心的支持下，向高成長的新興市場擴張是另一個關鍵策略。為了保持競爭力，製造商還提供模組化成像系統，以減少維護並允許更容易的升級。

產業生態系統分析
- 供應商格局
- 每個階段的增值
- 影響價值鏈的因素
產業衝擊力
- 成長動力
  - 醫學影像技術的漸進式創新與進步
  - 醫療支出增加
  - 老年人口基數快速成長，疾病負擔不斷加重
  - 人工智慧（AI）在放射學領域的出現
  - 有利的政府舉措
- 產業陷阱與挑戰
  - 成像設備成本高
  - 報銷政策的變化
- 市場機會
  - 新興市場的擴張
成長潛力分析
技術格局
監管格局
- 美國
- 歐洲
- 亞太地區
未來市場趨勢
2024年定價分析
差距分析
波特的分析
PESTEL分析

第4章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略展望矩陣
關鍵進展
- 併購
- 夥伴關係和合作
- 新產品發布
- 擴張計劃

第5章：市場估計與預測：按產品，2021 - 2034 年

主要趨勢
X光設備
- 數位的
  - 直接射線照相系統
  - 電腦放射成像系統
- 模擬
磁振造影
超音波
- 2D超音波
- 3D超音波
- 其他超音波檢查
電腦斷層掃描
核子造影
乳房X光檢查

第6章：市場估計與預測：依最終用途，2021 - 2034 年

主要趨勢
醫院
診斷中心
其他最終用途

第7章：市場估計與預測：按地區，2021 - 2034 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第8章：公司簡介

Canon Medical Systems
Carestream Health
Esaote
Fujifilm Holdings
GE HealthCare Technologies
Hologic
Konica Minolta
Koninklijke Philips
Samsung Medison
Shimadzu
Siemens Healthineers

簡介目錄

Product Code: 4786

The Global Medical Imaging Market was valued at USD 43.9 billion in 2024 and is estimated to grow at a CAGR of 5.7% to reach USD 75.8 billion by 2034. This growth is largely supported by the increasing burden of chronic diseases, a rising aging population, ongoing advancements in imaging technologies, and greater healthcare spending across both emerging and developed nations. Medical imaging continues to be a cornerstone in clinical diagnostics and treatment planning, as it enables healthcare providers to visualize internal organs, tissues, and bones in detail. These technologies help in early disease detection, guide minimally invasive procedures, and contribute to long-term patient management. Innovations in hardware and software, improved image clarity, and faster image processing are further elevating clinical decision-making, improving patient outcomes, and boosting demand worldwide.

Medical imaging relies on technologies that produce high-definition visual data to assist in clinical evaluations and surgical interventions. These tools have evolved into essential components of diagnostics, offering precision and speed across medical disciplines. Devices such as MRI systems, X-rays, CT scanners, and ultrasound machines are deployed across clinical settings to evaluate internal injuries, chronic conditions, and abnormalities. Their real-time imaging capabilities support diagnosis and improve workflow efficiency.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$43.9 Billion
Forecast Value	$75.8 Billion
CAGR	5.7%

In 2024, the X-ray devices segment led the market, primarily due to its increased usage for early diagnosis of chronic illnesses. This segment's growth is supported by the constant upgrades in X-ray technologies that now include AI-powered imaging solutions designed to ensure accuracy, streamline workflows, and reduce the burden on radiologists. These advanced systems have proven their efficacy in multicenter evaluations and are widely adopted across clinical setups. The incorporation of smart diagnostic capabilities is significantly enhancing provider confidence and contributing to the rising utilization of X-ray systems in modern medical imaging practices.

The hospitals segment held a 52.6% share in 2024. Their growing share is influenced by rapid urbanization, population growth, and a rise in healthcare infrastructure investments. The widespread installation of advanced diagnostic equipment, coupled with skilled professionals available to operate them, is positioning hospitals as dominant end-users in this market. Additionally, increased funding for hospital upgrades and new construction, especially across developing regions, is elevating the adoption of imaging equipment. Government and private investments in improving hospital infrastructure are driving significant demand for high-performance imaging technologies.

United States Medical Imaging Market was valued at USD 15.1 billion in 2024. The rising cancer prevalence across the country, stemming from environmental and lifestyle-related factors, has intensified the need for effective and advanced imaging tools for early cancer detection and monitoring. The growing incidence of such conditions is pushing hospitals and clinics to invest in imaging systems that offer high diagnostic value and patient-specific accuracy, thus accelerating overall market growth in the U.S.

Prominent companies operating in the Global Medical Imaging Market include GE HealthCare Technologies, Shimadzu, Samsung Medison, Carestream Health, Canon Medical Systems, Fujifilm Holdings, Hologic, Konica Minolta, Esaote, Siemens Healthineers, and Koninklijke Philips. Leading medical imaging companies are prioritizing innovation by investing in AI integration, machine learning algorithms, and automation to boost image accuracy and diagnostic speed. They are expanding their digital health platforms to support remote diagnostics, cloud-based image storage, and data interoperability. Global market players are actively pursuing mergers, acquisitions, and collaborations with hospitals and technology firms to broaden their solution portfolios. Expansion into high-growth emerging markets is another critical strategy, supported by localized manufacturing and service centers. To remain competitive, manufacturers are also offering modular imaging systems that reduce maintenance and allow for easier upgrades.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/country
1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
1.5 Primary research and validation
- 1.5.1 Primary sources
1.6 Forecast model
1.7 Research assumptions and limitations

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis
2.2 Key market trends
- 2.2.1 Product
- 2.2.2 End use
- 2.2.3 Regional
2.3 CXO perspectives: Strategic imperatives
- 2.3.1 Key decision points for industry executives
- 2.3.2 Critical success factors for market players
2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Supplier landscape
- 3.1.2 Value addition at each stage
- 3.1.3 Factor affecting the value chain
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Incremental innovations and advancements in medical imaging technology
  - 3.2.1.2 Rise in healthcare expenditure
  - 3.2.1.3 Increasing disease burden along with rapidly growing geriatric population base
  - 3.2.1.4 Emergence of artificial intelligence (AI) in radiology
  - 3.2.1.5 Favorable government initiatives
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of imaging devices
  - 3.2.2.2 Changes in reimbursement policies
- 3.2.3 Market opportunities
  - 3.2.3.1 Expansion in emerging markets
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory landscape
- 3.5.1 U.S.
- 3.5.2 Europe
- 3.5.3 Asia Pacific
3.6 Future market trends
3.7 Pricing analysis, 2024
3.8 Gap analysis
3.9 Porter’s analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy outlook matrix
4.7 Key developments
- 4.7.1 Mergers and acquisitions
- 4.7.2 Partnerships and collaborations
- 4.7.3 New product launches
- 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1 Key trends
5.2 X-ray devices
- 5.2.1 Digital
  - 5.2.1.1 Direct radiography systems
  - 5.2.1.2 Computed radiography systems
- 5.2.2 Analog
5.3 MRI
5.4 Ultrasound
- 5.4.1 2D Ultrasound
- 5.4.2 3D Ultrasound
- 5.4.3 Other ultrasounds
5.5 Computed tomography
5.6 Nuclear imaging
5.7 Mammography

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

6.1 Key trends
6.2 Hospitals
6.3 Diagnostic centers
6.4 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE